Marshall Wace
SPPI

Marshall Wace’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Marshall Wace’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-969,105
Closed -$1.23M – 4255
2021
Q4 		$1.23M Buy
+969,105
New +$1.73M ﹤0.01% 2366
2019
Q3 		– Sell
-316,970
Closed -$2.73M – 1990
2019
Q2 		$2.73M Buy
+316,970
New +$2.84M 0.02% 681
2019
Q1 		– Sell
-8,940
Closed -$78K – 2134
2018
Q4 		$78K Sell
8,940
-110,236
-92% -$1.4M ﹤0.01% 1399
2018
Q3 		$2M Buy
+119,176
New +$2.58M 0.02% 678

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Marshall Wace's SPPI Position: Q1 2022 in Review

Marshall Wace sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2022, closing a stake of 969,105 shares — an estimated $1.23M sold.

Marshall Wace first reported a position in SPPI in Q3 2018 and held it in 4 quarters. The position peaked at $2.73M in Q2 2019. 101 funds tracked by Wall St. Rank hold SPPI as of Q1 2022.

  • Marshall Wace reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Marshall Wace sold 969,105 Spectrum Pharmaceuticals Inc shares in Q1 2022, an estimated $1.23M.
  • Marshall Wace first reported a position in Spectrum Pharmaceuticals Inc in Q3 2018 and held it in 4 quarters.
  • Marshall Wace's Spectrum Pharmaceuticals Inc position peaked at $2.73M in Q2 2019.
  • 101 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2022.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.